Equibles does not estimate personal net worth.
Earlier roles on record: CFO at InspireMD, Inc. (NSPR) until June 30, 2025 and CFO at InspireMD, Inc. (NSPR) until December 12, 2024. InspireMD, Inc. reported in an 8-K filed June 3, 2025 that Craig Shore was terminated as Chief Financial Officer, effective June 30, 2025. InspireMD, Inc. reported in an 8-K filed December 12, 2024 that Craig Shore retired as Chief Financial Officer. The proxy statement of InspireMD, Inc. reports total compensation of $2,350,039 for Craig Shore in fiscal 2025, including a base salary of $261,099. Disclosed compensation is on record for 8 fiscal years. Craig Shore has spoken on 18 earnings calls across 1 company, most recently for InspireMD, Inc. on May 9, 2025. The companies whose calls Craig Shore spoke on are classified in the Healthcare sector.
“On the Effective Date, Mr. Lawless will succeed Craig Shore, whose employment as the Company's Chief Financial Officer will be terminated simultaneous with Mr. Lawless's appointment.”
“On December 12, 2024, InspireMD, Inc. (the “Company”) announced that Craig Shore has decided to retire from his role as Chief Financial Officer of the Company, effective upon the appointment of his successor.”
“For the first quarter of 2025, total revenue increased 1.2% to $1,529,000. This increase was driven by growth in existing markets, offset by the impact of foreign exchange and distributors managing CGuard inventory levels in anticipation of CGuard Prime approval in Europe.”
“For the fourth quarter of 2024, total revenue increased 10.6% to $1.9 million from $1.7 million during the fourth quarter of 2023. This increase was predominantly driven by growth in existing and new markets.”
“For the three months ended September 30, 2024, revenue increased by $254,000, or 16.3%, to $1,810,000 from $1,556,000 during the same period last year. This increase was driven by growth in existing and new markets.”
“For the second quarter ended June 30, 2024, revenue increased by $90,000 or 5.4% to $1,739,000 from $1,649,000 during the second quarter ended June 30, 2023.”
“For the first quarter of 2024, total revenue increased 22% to $1,511,000 from $1,239,000 during the first quarter of 2023. This increase was predominantly driven by growth in existing markets.”
Start not stated–2024-12-12
Start not stated–2025-06-30
NSPR
Medical Devices · Healthcare
CFO
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | InspireMD, Inc. (NSPR) | Former Chief Financial Officer, Chief Administrative Officer, Secretary and Treasurer \ | $261,099 | $2,350,039 |
| 2024 | InspireMD, Inc. (NSPR) | Chief Financial Officer, Secretary and Treasurer | $319,894 | $1,636,723 |
| 2023 | InspireMD, Inc. (NSPR) | Chief Financial Officer, Secretary and Treasurer | $305,426 | $1,801,240 |
| 2022 | InspireMD, Inc. (NSPR) | Chief Financial Officer, Secretary and Treasurer | $319,524 | $625,235 |
| 2021 | InspireMD, Inc. (NSPR) | Chief Financial Officer, Secretary and Treasurer | $319,569 | $1,056,861 |
| 2020 | InspireMD, Inc. (NSPR) | Chief Financial Officer, Secretary and Treasurer | $265,004 | $869,022 |
| 2019 | InspireMD, Inc. (NSPR) | Chief Financial Officer, Secretary and Treasurer | $269,758 | $501,153 |
| 2018 | InspireMD, Inc. (NSPR) | Chief Financial Officer, Secretary and Treasurer | $267,306 | $463,371 |
